Home Business Industry NAFDAC Announces Ban On Sale, Use Of 101 Drugs
Industry

NAFDAC Announces Ban On Sale, Use Of 101 Drugs

Share
Share

The National Agency for Food and Drug Administration and Control (NAFDAC) on Tuesday announced the withdrawal, suspension, or cancellation of 101 pharmaceutical products, effective immediately.

NAFDAC, which made the announcement through a statement released on the Agency X handle on Tuesday, said affected products “are therefore no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale and use within Nigeria.”
It explained that the list of products can be accessed on the NAFDAC website.

It was gathered that the discontinued products include widely used drugs like Abacavir and Amlodipine.

The list covers hundreds of items across medicines and health products from antimalarials (various artemether/lumefantrine formulations) and cardiovascular drugs (valsartan products) to insulin/growth-hormone injectables (Norditropin), diabetes medicines (Januvia/Janumet), inhalers and eye drops.

Share

Businesstoday Magazine

Businesstoday Conference/Awards

Related Articles

Nigeria Advances Pharmaceutical Regulation As NAFDAC Becomes ICH Member

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human...

BoI Disburses ₦1.27trn, Backs 900,000 Jobs In 2024

The Bank of Industry (BoI) has disbursed over ₦1.27 trillion to enterprises...

Manufacturers Press For Interest Rate Cut After MPC Retains 27% Benchmark

Following  the high cost of borrowing continues to hinder production and weaken...

FG Celebrates N4b, €185,733,496 In Ajaokuta Contract Dispute With French Firm

FG Celebrates N4b , €185,733,496 In Arbitration Case Victory Against French Firm...